Huijie Yang

Henan Key Laboratory Of Immunology And Targeted Drugs
Xinxiang, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

Correction: RBCK1 regulates the progression of ER-positive breast cancer through the HIF1α signaling.

Correction: RBCK1 regulates the progression of ER-positive breast cancer through the HIF1α signaling.

Journal: Cell death & disease
Published: February 05, 2026

Recruiting T-cells toward the brain for enhanced glioblastoma chemo-immunotherapy efficacy by co-delivery of cytokines and temozolomide via ultrasound-gated redox-responsive extracellular vesicles.

Recruiting T-cells toward the brain for enhanced glioblastoma chemo-immunotherapy efficacy by co-delivery of cytokines and temozolomide via ultrasound-gated redox-responsive extracellular vesicles.

Journal: Journal of nanobiotechnology
Published: August 04, 2025

SOX4 induces cisplatin resistance in cervical cancer cells by inhibiting aerobic glycolysis.

SOX4 induces cisplatin resistance in cervical cancer cells by inhibiting aerobic glycolysis.

Journal: Cell death discovery
Published: March 08, 2025

Oxytocin Receptor Regulates the Hippo/YAP Axis to Drive Hepatocarcinogenesis.

Oxytocin Receptor Regulates the Hippo/YAP Axis to Drive Hepatocarcinogenesis.

Journal: Cancer research
Published: September 18, 2024

YAP represses the TEAD-NF-κB complex and inhibits the growth of clear cell renal cell carcinoma.

YAP represses the TEAD-NF-κB complex and inhibits the growth of clear cell renal cell carcinoma.

Journal: Science signaling
Published: July 02, 2024

USP36 promotes tumorigenesis and tamoxifen resistance in breast cancer by deubiquitinating and stabilizing ERα.

USP36 promotes tumorigenesis and tamoxifen resistance in breast cancer by deubiquitinating and stabilizing ERα.

Journal: Journal of experimental & clinical cancer research : CR
Published: May 10, 2024

Regulation of the Hippo/YAP axis by CXCR7 in the tumorigenesis of gastric cancer.

Regulation of the Hippo/YAP axis by CXCR7 in the tumorigenesis of gastric cancer.

Journal: Journal of experimental & clinical cancer research : CR
Published: June 20, 2023

USP1 modulates hepatocellular carcinoma progression via the Hippo/TAZ axis.

USP1 modulates hepatocellular carcinoma progression via the Hippo/TAZ axis.

Journal: Cell death & disease
Published: November 22, 2022

RNF31 represses cell progression and immune evasion via YAP/PD-L1 suppression in triple negative breast Cancer.

RNF31 represses cell progression and immune evasion via YAP/PD-L1 suppression in triple negative breast Cancer.

Journal: Journal of experimental & clinical cancer research : CR
Published: July 15, 2022

RBCK1 is an endogenous inhibitor for triple negative breast cancer via hippo/YAP axis.

RBCK1 is an endogenous inhibitor for triple negative breast cancer via hippo/YAP axis.

Journal: Cell communication and signaling : CCS
Published: May 05, 2022

OTUB1 suppresses Hippo signaling via modulating YAP protein in gastric cancer.

OTUB1 suppresses Hippo signaling via modulating YAP protein in gastric cancer.

Journal: Oncogene
Published: April 04, 2022

UHRF1 modulates breast cancer cell growth via estrogen signaling.

UHRF1 modulates breast cancer cell growth via estrogen signaling.

Journal: Medical oncology (Northwood, London, England)
Published: January 29, 2022
Showing 1-12 of 23

Last Updated: 09/26/2026